Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome

ClinicalTrials.gov ID: NCT02658175

Public ClinicalTrials.gov record NCT02658175. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 12:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ISIS 304801-CS7 The APPROACH Open Label Study Volanesorsen (ISIS 304801) An Open-Label Study of Volanesorsen Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

An open-label study of volanesorsen (ISIS 304801) administered subcutaneously to participants with FCS.

Study identification

NCT ID
NCT02658175
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Akcea Therapeutics
Industry
Enrollment
68 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 23, 2015 (Actual)
Primary completion
Jan 15, 2020 (Actual)
Completion
Jan 15, 2020 (Actual)
Last update posted
Aug 26, 2021

2015 – 2020

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
IONIS Investigative Site Huntington Beach California 94143 —
IONIS Investigative Site San Francisco California 94143 —
IONIS Investigative Site Boca Raton Florida 33434 —
IONIS Investigative Site Boston Massachusetts 02114 —
IONIS Investigative Site Philadelphia Pennsylvania 19104 —
IONIS Investigative Site Houston Texas 77030 —
IONIS Investigative Site Norfolk Virginia 23510 —
IONIS Investigative Site Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02658175, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2021 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02658175 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →